Related Experiment Video

Updated: Nov 17, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.6K

Novel biomarkers in cardiovascular surgery

Raffaele Serra1,2, Federica Jiritano3, Umberto M Bracale4

  • 1Department of Medical & Surgical Sciences, University of Catanzaro, Italy.

Biomarkers in Medicine
|February 16, 2021
PubMed

Insights

Cardiovascular disease biomarkers aid in identifying high-risk patients and tailoring surgical treatments. These markers improve diagnosis, prognosis, and patient follow-up for heart, artery, and vein conditions.

Area of Science:

  • Cardiology
  • Biomarker Discovery
  • Surgical Decision Support

Background:

  • Cardiovascular disease (CVD) is a major global health issue, encompassing heart, artery, and vein conditions.
  • CVD can manifest acutely or chronically, often with frequent relapses.
  • Accurate diagnosis and treatment decisions are crucial for managing CVD.

Purpose of the Study:

  • To identify and analyze key biomarkers for cardiovascular disease.
  • To evaluate the clinical and surgical significance of identified biomarkers.
  • To explore how biomarkers can enhance patient management in cardiovascular care.

Main Methods:

  • Systematic literature search across Medline, Scopus, and ScienceDirect databases.
  • Analysis of retrieved articles focusing on cardiovascular biomarkers.
  • Evaluation of biomarker importance from clinical and surgical perspectives.

Main Results:

  • Several clinically and surgically relevant biomarkers for cardiovascular disease were identified.
  • Biomarkers demonstrate utility in identifying high-risk individuals.
  • Biomarkers provide valuable information for prognosis and surgical treatment planning.

Conclusions:

  • Biomarkers are essential tools in managing cardiovascular disease.
  • They facilitate improved diagnostic accuracy and patient risk stratification.
  • Biomarkers support personalized surgical treatment strategies and enhance patient follow-up.

Keywords:
arteriesbiomarkerscardiovascularheartsurgeryveins

More Related Videos

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.6K
Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.3K

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
536
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
333
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
125
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
90